| RS2522551580 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2522551905 |
TYMP
|
Health Risk |
Pathogenic |
— |
| RS2522552599 |
DMD
|
Health Risk |
Likely pathogenic |
Myopathy, Myopathy |
| RS2522552894 |
PHKA1
|
Health Risk |
Pathogenic |
Glycogen storage disease IXd, Glycogen storage disease IXd |
| RS2522553272 |
DMD
|
Health Risk |
Pathogenic |
Muscular dystrophy, Duchenne muscular dystrophy |
| RS2522553864 |
COL9A2
|
Health Risk |
Likely pathogenic |
— |
| RS2522557237 |
COL9A2
|
Health Risk |
Pathogenic |
— |
| RS2522557278 |
COL9A2
|
Health Risk |
Pathogenic |
— |
| RS2522561294 |
COL9A2
|
Health Risk |
Likely pathogenic |
COL9A2-related disorder, COL9A2-related disorder |
| RS2522565446 |
DMD
|
Health Risk |
Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dystrophin, Neuromuscular disease caused by qualitative or quantitative defects of dystrophin |
| RS2522565802 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2522565997 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2522566050 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2522567971 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2522568739 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS2522569580 |
DMD
|
Health Risk |
Likely pathogenic |
Becker muscular dystrophy, Duchenne muscular dystrophy |
| RS2522569884 |
COL9A2
|
Health Risk |
Pathogenic |
— |
| RS2522570520 |
COL9A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2522573422 |
DMD
|
Health Risk |
Likely pathogenic |
— |
| RS2522581753 |
GRHL3
|
Health Risk |
Likely pathogenic |
— |
| RS2522582333 |
GRHL3
|
Health Risk |
Likely pathogenic |
Van der Woude syndrome 2, Van der Woude syndrome 2 |
| RS2522584464 |
XIAP
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to XIAP deficiency, X-linked lymphoproliferative disease due to XIAP deficiency |
| RS2522585183 |
XIAP
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to XIAP deficiency, X-linked lymphoproliferative disease due to XIAP deficiency |
| RS2522585460 |
XIAP
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to XIAP deficiency, X-linked lymphoproliferative disease due to XIAP deficiency |
| RS2522585616 |
XIAP
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked lymphoproliferative disease due to XIAP deficiency, X-linked lymphoproliferative disease due to XIAP deficiency |
| RS2522585961 |
XIAP
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to XIAP deficiency, X-linked lymphoproliferative disease due to XIAP deficiency |
| RS2522587785 |
OPN1LW
|
Health Risk |
Likely pathogenic |
Protan defect, Protan defect |
| RS2522589875 |
NPHP4
|
Health Risk |
Pathogenic |
Nephronophthisis 4, Nephronophthisis 4 |
| RS2522590553 |
XIAP
|
Health Risk |
Likely pathogenic |
XIAP-related disorder, XIAP-related disorder |
| RS2522596299 |
XIAP
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to XIAP deficiency, X-linked lymphoproliferative disease due to XIAP deficiency |
| RS2522596304 |
XIAP
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to XIAP deficiency, X-linked lymphoproliferative disease due to XIAP deficiency |
| RS2522596336 |
XIAP
|
Health Risk |
Pathogenic |
X-linked lymphoproliferative disease due to XIAP deficiency, XIAP-related disorder |
| RS2522599015 |
ALDH4A1
|
Health Risk |
Likely pathogenic |
Hyperprolinemia type 2, Hyperprolinemia type 2 |
| RS2522603990 |
RSPO1
|
Health Risk |
Likely pathogenic |
Palmoplantar keratoderma-XX sex reversal-predisposition to squamous cell carcinoma syndrome, RSPO1-related disorder |
| RS2522608482 |
GRHL3
|
Health Risk |
Likely pathogenic |
Van der Woude syndrome 2, Van der Woude syndrome 2 |
| RS2522617063 |
ALDH4A1
|
Health Risk |
Likely pathogenic |
Hyperprolinemia type 2, Hyperprolinemia type 2 |
| RS2522618803 |
C8A
|
Health Risk |
Pathogenic |
— |
| RS2522621962 |
GRHL3
|
Health Risk |
Likely pathogenic |
GRHL3-related disorder, GRHL3-related disorder |
| RS2522622618 |
GRHL3
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2522625136 |
XIAP
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked lymphoproliferative disease due to XIAP deficiency, X-linked lymphoproliferative disease due to XIAP deficiency |
| RS2522637013 |
KDM6A
|
Health Risk |
Pathogenic |
— |
| RS2522637621 |
KDM6A
|
Health Risk |
Pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS2522646617 |
GRHL3
|
Health Risk |
Likely pathogenic |
Van der Woude syndrome 2, Van der Woude syndrome 2 |
| RS2522663621 |
BCORL1
|
Health Risk |
Likely pathogenic |
Shukla-Vernon syndrome, Shukla-Vernon syndrome |
| RS2522669795 |
MECR
|
Health Risk |
Pathogenic |
— |
| RS2522671934 |
KDM6A
|
Health Risk |
Pathogenic |
Kabuki syndrome 2, Kabuki syndrome 2 |
| RS2522672708 |
ALDH4A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperprolinemia type 2, Hyperprolinemia type 2 |
| RS2522684220 |
MECR
|
Health Risk |
Pathogenic |
— |
| RS2522684473 |
FGD1
|
Health Risk |
Likely pathogenic |
Aarskog syndrome, Aarskog syndrome |
| RS2522688358 |
FGD1
|
Health Risk |
Likely pathogenic |
Aarskog syndrome, Aarskog syndrome |
| RS2522688418 |
FGD1
|
Health Risk |
Likely pathogenic |
Aarskog syndrome, Aarskog syndrome |
| RS2522689025 |
AGRN
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 8, Congenital myasthenic syndrome 8 |
| RS2522690335 |
SLC30A2
|
Health Risk |
Likely pathogenic |
Zinc deficiency, transient neonatal |
| RS2522691572 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2522691621 |
FGD1
|
Health Risk |
Likely pathogenic |
— |
| RS2522691806 |
AGRN
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 8, Congenital myasthenic syndrome 8 |
| RS2522692204 |
FGD1
|
Health Risk |
Pathogenic |
Aarskog syndrome, Aarskog syndrome |
| RS2522692782 |
RERE
|
Health Risk |
Pathogenic |
— |
| RS2522692819 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2522693820 |
FGD1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2522693895 |
FGD1
|
Health Risk |
Pathogenic |
Aarskog syndrome, Aarskog syndrome |
| RS2522695366 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2522697912 |
DEPDC5
|
Health Risk |
Pathogenic |
Familial focal epilepsy with variable foci, Familial focal epilepsy with variable foci |
| RS2522697979 |
RERE
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without anomalies of the brain, eye |
| RS2522698895 |
FGD1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2522698958 |
FGD1
|
Health Risk |
Likely pathogenic |
Aarskog syndrome, Aarskog syndrome |
| RS2522700010 |
FGD1
|
Health Risk |
Pathogenic |
— |
| RS2522706561 |
ESPN
|
Health Risk |
Likely pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS2522707034 |
RERE
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without anomalies of the brain, eye |
| RS2522708942 |
FGD1
|
Health Risk |
Likely pathogenic |
— |
| RS2522709066 |
FGD1
|
Health Risk |
Pathogenic |
Aarskog syndrome, Aarskog syndrome |
| RS2522709567 |
FGD1
|
Health Risk |
Pathogenic |
Aarskog syndrome, Aarskog syndrome |
| RS2522709643 |
FGD1
|
Health Risk |
Pathogenic |
Aarskog syndrome, Aarskog syndrome |
| RS2522710840 |
ATP13A2
|
Health Risk |
Likely pathogenic |
Neurodegeneration with brain iron accumulation, Neurodegeneration with brain iron accumulation |
| RS2522711086 |
FLNA
|
Health Risk |
Pathogenic |
Heterotopia, periventricular |
| RS2522712579 |
FLNA
|
Health Risk |
Likely pathogenic |
Frontometaphyseal dysplasia 1, Frontometaphyseal dysplasia 1 |
| RS2522713003 |
FLNA
|
Health Risk |
Pathogenic |
Heterotopia, periventricular |
| RS2522713596 |
FLNA
|
Health Risk |
Pathogenic |
Heterotopia, periventricular |
| RS2522714066 |
FLNA
|
Health Risk |
Pathogenic |
Melnick-Needles syndrome, Oto-palato-digital syndrome |
| RS2522714571 |
FGD1
|
Health Risk |
Pathogenic |
— |
| RS2522714778 |
FLNA
|
Health Risk |
Likely pathogenic |
FLNA-related disorder, Cardiac valvular dysplasia |
| RS2522715027 |
FLNA
|
Health Risk |
Pathogenic |
Familial thoracic aortic aneurysm and aortic dissection, Familial thoracic aortic aneurysm and aortic dissection |
| RS2522715055 |
FLNA
|
Health Risk |
Pathogenic |
Melnick-Needles syndrome, Heterotopia |
| RS2522715270 |
FGD1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2522715548 |
FGD1
|
Health Risk |
Likely pathogenic |
— |
| RS2522715770 |
FGD1
|
Health Risk |
Pathogenic |
— |
| RS2522715819 |
KDF1
|
Health Risk |
Pathogenic |
— |
| RS2522716211 |
RERE
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without anomalies of the brain, eye |
| RS2522716301 |
KDF1
|
Health Risk |
Likely pathogenic |
Hypodontia, Hypodontia |
| RS2522716359 |
FGD1
|
Health Risk |
Pathogenic |
FGD1-related disorder, FGD1-related disorder |
| RS2522716847 |
RERE
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without anomalies of the brain, eye |
| RS2522717190 |
AGRN
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 8, Congenital myasthenic syndrome 8 |
| RS2522719482 |
FLNA
|
Health Risk |
Likely pathogenic |
FLNA-related disorder, FLNA-related disorder |
| RS2522719685 |
FLNA
|
Health Risk |
Likely pathogenic |
FLNA-related disorder, FLNA-related disorder |
| RS2522719819 |
FLNA
|
Health Risk |
Pathogenic |
Oto-palato-digital syndrome, type II |
| RS2522721064 |
FLNA
|
Health Risk |
Pathogenic |
— |
| RS2522721432 |
FLNA
|
Health Risk |
Pathogenic |
Melnick-Needles syndrome, Oto-palato-digital syndrome |
| RS2522721656 |
FLNA
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Frontometaphyseal dysplasia |
| RS2522721718 |
FLNA
|
Health Risk |
Pathogenic |
Melnick-Needles syndrome, Oto-palato-digital syndrome |
| RS2522722829 |
C8B
|
Health Risk |
Pathogenic |
— |